title: Does levosimendan act as a Ca2+sensitizer or PDE3 inhibitor?: Commentary on Orstavik et al., Br J Pharmacol 171: 5169-5181.
abstract: This article is a Commentary on Orstavik O, Ata SH, Riise J, Dahl CP, Andersen GO, Levy FO, Skomedal T, Osnes J-B, and Qvigstad E (2014). PDE3-inhibition by levosimendan is sufficient to account for its inotropic effect in failing human heart . Br J Pharmacol 171: 5169-5181. doi: 10.1111/bph.12647.
authors.affiliation: Department of Pharmacology, Yamagata University School of Medicine, Yamagata, Japan.
authors.forename: Masao
authors.initials: M
authors.lastname: Endoh
keywords: Ca2+ sensitizer; OR-1896; amrinone; cilostamide; levosimendan; omecamtiv mecarbil; phosphodiesterase inhibitor; pimobendan; positive inotropic effect